Thursday, May 19, 2022

Former cyclist Danilo Hondo sanctioned for blood doping

BERN, Switzerland ( Associated Press) — Former professional cyclist Danilo Hondo was suspended Friday for blood doping revealed in an Austrian-led investigation and given a reduced sentence for his confession and cooperation.

Hondo was sanctioned by a sports court in Switzerland, a country where the German was registered as a cyclist and worked as a coach for young cyclists at the time he was implicated in the Operation Aderlass case that revealed a blood doping network.

Hondo, 48, has been banned from working on sports matters for two and a half years — dating back to September 2019 and now expired — with a further five and a half year suspension due to his “confession and extensive cooperation ”, reported the Swiss Olympic Committee.

Read Also:  Atlanta takes home win streak into matchup with New Orleans

Hondo competed at the 1996 Atlanta Olympics for the German track pursuit team. In a long road race he won two stages at the 2001 Giro d’Italia, where he was runner-up in the points classification.

He previously served a suspension after being caught doping in 2005.

Hondo was a coach for the Swiss cycling federation in 2019 when Austrian investigators revealed a doping ring involving blood transfusions linked to a doctor in Germany.

The former cyclist admitted in an interview with the German media consortium ARD that he has been doping since 2011, near the end of his career.

The Swiss court ordered Hondo to pay compensation of 12,500 Swiss francs ($12,500) plus the legal costs of his disciplinary investigation.

Read Also:  Disposable Gloves Market Size, Share & Trends Analysis Report 2022-2030 - ResearchAndMarkets.com
Nation World News Desk
Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here